(Credit: National Cancer Centre Singapore)
Singapore, 15th May 2022 – For the first time in Singapore, buildings and landmarks around the Marina Bay Water Promenade (see Annex for full list of buildings) will be lit up in green and blue to raise awareness of Neurofibromatosis, a commonly undiagnosed genetic condition. The initiative spearheaded by National Cancer Centre Singapore, is to mark World Neurofibromatosis (NF) Awareness Month in May.
Affecting millions worldwide, Neurofibromatosis is a genetic condition that causes tumours to grow on nerves in the spinal cord, brain and other parts of the body. The most common type of NF is NF1, which is estimated to occur in one in every 2,000 – 3,000 individuals globally. The tumours are usually non-cancerous but can sometimes become cancerous. Early screening and diagnosis allows timely management and treatment of symptoms and complications, contributing to better outcomes for NF1 patients. For more info on NF1, click
here.
‘Shine a Light on NF’ is a global movement that raises awareness about Neurofibromatosis in the community by lighting up buildings, bridges, monuments and other landmarks in blue and green.
(Credit: National Cancer Centre Singapore)
Joining the global movement to ‘Shine a Light on NF’ is National Cancer Centre Singapore (NCCS). On 14 May, NF1 patients and their families were joined by staff from NCCS’ Cancer Genetics Service to view the light up around the Marina Bay Water Promenade. A public forum1 on Neurofibromatosis was also held on the same day with healthcare professionals from NCCS sharing on latest medical and research updates and tips to manage the genetic condition.
1https://www.nccs.com.sg/events/patient-care/living-with-neurofibromatosis-type-1
ANNEX
S/N
|
Building |
Date & Time of Light Up
|
Colours
|
1
| One Raffles Place
| 14 to 17 May 2022
7.00pm to 12am | Blue and Green
|
2
| National Gallery | 14 to 17 May 2022
6.30 pm to 12am | Blue and Green |
3
| The Helix Bridge | 14 to 17 May 2022
7.00pm to 12am | Blue |
4
| Singapore Flyer | 17 May
7.30pm to 10.30pm | Blue |
5
| Republic Plaza | 14 to 17 May 2022
7.00pm to 11.00pm | Blue |
6
| Ocean Financial Centre
| 14 to 17 May 2022
7.30pm to 11.00pm | Blue |
For media enquiries, please contact:
Lien Wanting
National Cancer Centre Singapore
Corporate Communications
Email: lien.wanting@nccs.com.sg
About National Cancer Centre Singapore
The National Cancer Centre Singapore (NCCS) is a leading national and regional tertiary cancer centre with specialists who are experts in treating cancer. NCCS attends to the majority of cancer cases in Singapore’s public healthcare sector. In addition to offering holistic and multidisciplinary oncology care, our clinicians and scientists collaborate with local and international partners to conduct robust, cutting-edge clinical and translational research. To achieve the vision of being a global leading cancer centre, NCCS offers world class care and shares its depth of experience and expertise by training local and overseas medical professionals.
To meet growing needs, the new NCCS building will be completed in 2022 with increased capacity and expanded facilities dedicated to cancer care, rehabilitation, research and education. To give patients the best treatment outcomes, NCCS will offer access to advanced and innovative treatment such as proton therapy at the new Goh Cheng Liang Proton Therapy Centre.
For more information, please visit: www.nccs.com.sg
